Home » Topics » BioWorld Science

BioWorld Science
RSS

Potent, orally active antiplatelet agent discovered by Merck & Co.

Nov. 28, 1996

Company profile: MediGene

Nov. 28, 1996

Novel anticonvulsant described by SmithKline Beecham

Nov. 28, 1996

NEP inhibitors claimed by Santen

Nov. 28, 1996

Natural farnesyltransferase inhibitors from Kitasato Institute

Nov. 28, 1996

Natural antiplatelet agent discovered at Kitasato Institute

Nov. 28, 1996

Reversible cysteine protease inhibitors reported by Arris

Nov. 28, 1996

PDE IV inhibitors reported by E. Merck

Nov. 28, 1996

New antibacterial agents under study at Bayer

Nov. 28, 1996

Trinity Biotech obtains license option for hepatitis A antigens

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...